Rain Therapeutics

Rain Therapeutics

Developing small molecule targeted therapeutics for cancer patients that possess a clear, and single, oncogenic driver. Learn more

Launch date
Employees
Market cap
CAD60.0m
Enterprise valuation
(CAD45m) (Public information from Jan 2024)
Fremont California (HQ)
Authorizing premium user...